Two new reports find impacts of COVID-19 on clinical trials easing slightly According to findings released by GlobalData Healthcare (9 July, 2020) disruption caused to clinical trials by the COVID-19 pandemic is beginning to ease slightly. After three months of increasing disruptions to trials largely attributed to suspended enrolment there is some evidence of green shoots. Trials that were disrupted due to suspended enrolment are showing signs of recovery
FDA launches pioneering pilot to make public patient reported outcomes of clinical trials This week (23 June, 2020) the US Food and Drug Administration (FDA) launched a pioneering pilot project Patient Voice. It is an open source web portal that will for the first time make publicly accessible the information about patient-reported symptoms during cancer clinical trials. The project was initiated by the Oncology Center of Excellence to
Cromos Pharma Recruits over 300 Patients in Under Two Months into a COVID-19 Clinical Trial June 18, 2020 – Portland, OR. Cromos Pharma, an international CRO, is pleased to announce unprecedented recruitment in a phase IIb trial in patients with moderate to severe COVID-19 infection. It has successfully recruited over 300 patients in under two months to the trial. “We are very proud of our team for this fantastic accomplishment,”
